Deferoxamine decreases necrosis in dorsally based pig skin flaps.
Deferoxamine, a free radical scavenger and iron chelator, has been shown to improve skin flap survival in ischemic flap surgery in rats. The present study investigates the value of deferoxamine in ischemic flap surgery in the porcine model. Four 4 x 12 cm flaps, 3 cm apart and 3 cm from the dorsal midline, were elevated on each of six female pigs, weighing 50 to 60 pounds each. The animals were divided into two test groups. Group 1 received six 1 gm doses of deferoxamine in 4 ml of sterile water intramuscularly every 6 hours preoperatively for five doses, followed by the administration of 1 g every 6 hours for the first 6 days postoperatively. Group 2 received 4 ml of normal saline administered intramuscularly as above. The percentage of flap necrosis was assessed on postoperative day 7 by the weighing paper technique. Group 1 had 17.1% necrosis and group 2 had 33% necrosis (p less than 0.005). Deferoxamine has decreased flap necrosis in the porcine model and may be of use in augmenting the surviving length of flaps in human beings.
Weinstein
G S
GS
Department of Otolaryngology-Head and Neck Surgery, University of Iowa Hospital and Clinics, Iowa City 52246.
Maves
M D
MD
McCormack
M L
ML
D000818:Animals; D003676:Deferoxamine / Q000494:pharmacology*; D005260:Female; D006085:Graft Survival / Q000187:drug effects*; D007273:Injections, Intramuscular; D009336:Necrosis; D013524:Surgical Flaps / Q000473:pathology*; D013552:Swine; D014945:Wound Healing / Q000187:drug effects
D003676:Deferoxamine